Concomitant Liver Biopsy During Bariatric Surgery: No Increase in Major Complications or Readmissions but Associated with Higher Transfusion Requirements - An Analysis of the MBSAQIP Database - Takeaways - MDSpire

Concomitant Liver Biopsy During Bariatric Surgery: No Increase in Major Complications or Readmissions but Associated with Higher Transfusion Requirements - An Analysis of the MBSAQIP Database

  • By

  • Juan S. Barajas-Gamboa

  • Kayanne Khoury

  • Valentin Mocanu

  • Mélissa V. Wills

  • Thomas H. Shin

  • Gustavo Romero-Velez

  • Matthew Allemang

  • Andrew T. Strong

  • Salvador Navarrete

  • Ricard Corcelles

  • A. Daniel Guerron

  • John Rodriguez

  • Matthew Kroh

  • Jerry T. Dang

  • September 25, 2025

  • 0 min

Share

  • 1

    Morbid obesity significantly contributes to the prevalence of Metabolic dysfunction–associated steatotic liver disease (MASLD), especially in bariatric surgery candidates.

  • 2

    Concomitant liver biopsy during bariatric surgery does not increase major complications or readmissions but is associated with higher transfusion requirements.

  • 3

    Liver biopsy remains the gold standard for diagnosing MASLD and provides crucial prognostic information for patients at risk of severe liver disease.

  • 4

    The study utilized the MBSAQIP database from 2020 to 2022, reflecting contemporary practice patterns and enhancing the analysis of liver biopsy safety.

  • 5

    Despite its benefits, the practice of performing liver biopsy during bariatric surgery is controversial due to concerns about increased operative complications.

Original Source(s)

Concomitant Liver Biopsy During Bariatric Surgery: No Increase in Major Complications or Readmissions but Associated with Higher Transfusion Requirements - An Analysis of the MBSAQIP Database

  • by Juan S. Barajas-Gamboa, Kayanne Khoury, Valentin Mocanu, Mélissa V. Wills, Thomas H. Shin, Gustavo Romero-Velez, Matthew Allemang, Andrew T. Strong, Salvador Navarrete, Ricard Corcelles, A. Daniel Guerron, John Rodriguez, Matthew Kroh, Jerry T. Dang

  • September 25, 2025

Related Content

Laparoscopic Transcystic Common Bile Duct Exploration for the Treatment of Choledocholithiasis Following Roux-en-Y Gastric Bypass

To Fix or Not to Fix: Effect of Gastropexy on Esophageal Manometric Values Post Laparoscopic Sleeve Gastrectomy

A Smarter Screen for Sleep Apnea Stimulation

A four-factor staging system stratified response rates from 90.9% to 37.5% in a retrospective cohort study, although the model showed only moderate discrimination (C statistic, 0.68) and requires external validation